NCT02577315 - Demonstrate Bioequivalence of Two 12.5 mg Empagliflozin/500 mg Metformin Fixed Dose Combination Tablets With Free Combination of Empagliflozin 25 mg and Metformin 1000 mg in Healthy Male and Female Volunteers Under Fed Conditions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions

Healthy

Interventions

DRUG

Empagliflozin

Test Therapy - fixed dose combination of 2 tablets of 12.5 mg Empagliflozin and 500 mg Metformin

DRUG

Metformin

Test Therapy - fixed dose combination of 2 tablets of 12.5 mg Empagliflozin and 500 mg Metformin

DRUG

Empagliflozin

Reference Therapy - free combination of 1 tablets of 25 mg Empagliflozin and 1000 mg Metformin

DRUG

Metformin

Reference Therapy - free combination of 1 tablets of 25 mg Empagliflozin and 1000 mg Metformin

Trial Locations (1)

1276.27.001 Boehringer Ingelheim Investigational Site, Saint Petersburg